Literature DB >> 28394804

Risk factors, prevalence, and site concordance of human papillomavirus in high-risk Greek men.

Savas Tsikis1, Lea Hoefer1, George Bethimoutis2, Electra Nicolaidou2, Vassilios Paparizos2, Christina Antoniou2, Leonidas Chardalias3, Georgios-Emmanouil Stavropoulos3, Shruti Sharma4, Bradley C Long4, Ibro Mujacic4, Sabah Kadri4, Jeremy P Segal4, Larissa V Furtado4, John Schneider5,6, Angella Charnot-Katsikas4.   

Abstract

The aim of this study was to determine the risk factors, genotype-specific prevalence, and concordance of human papillomavirus (HPV) infections at three anatomical sites in a cohort of high-risk Greek men. Patients were recruited from sexually transmitted infection and HIV clinics in Athens. Samples were obtained from oral, penile, and anal sites of 294 study participants and HPV testing was performed on 882 samples using next-generation sequencing. Patients also completed a questionnaire assessing risk factors for infection. The mean age of the participants was 33.1, 30% identified as men who have sex with men (MSM), and 21% were HIV positive. The prevalence of HPV was 49%; it was the highest at anal sites (33%) compared with 23% at penile sites (P=0.008) and 4% at oral sites (P<0.001). The most common HPV types in order of frequency were 6, 44, 16, 53, and 89. The genotype concordance rate was the highest between the penile and anal sites (7%), followed by 2% for anal-oral concordance. Identifying as MSM [adjusted odds ratios (aOR)=6.75, P<0.001] and being HIV positive (aOR=2.89, P=0.026) were significant risk factors for anal HPV infection, whereas alcohol use (aOR=0.45, P=0.002) was associated negatively with infection. The only significant risk factor for oral infection was an older age of sexual debut (aOR=1.32, P=0.038). Nearly half of our study participants tested positive in at least one of three anatomical sites. Using next-generation sequencing, we could identify high-risk types that are not covered by the current vaccine and would be missed by traditional HPV testing kits.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28394804      PMCID: PMC5631955          DOI: 10.1097/CEJ.0000000000000366

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  25 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

Review 2.  Financial crisis and austerity measures in Greece: their impact on health promotion policies and public health care.

Authors:  Amalia A Ifanti; Andreas A Argyriou; Foteini H Kalofonou; Haralabos P Kalofonos
Journal:  Health Policy       Date:  2013-06-19       Impact factor: 2.980

Review 3.  Prevalence of HPV infection among men: A systematic review of the literature.

Authors:  Eileen F Dunne; Carrie M Nielson; Katherine M Stone; Lauri E Markowitz; Anna R Giuliano
Journal:  J Infect Dis       Date:  2006-09-12       Impact factor: 5.226

Review 4.  Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review.

Authors:  Aimee R Kreimer; Gary M Clifford; Peter Boyle; Silvia Franceschi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

5.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

Review 6.  Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions.

Authors:  Brooke E Hoots; Joel M Palefsky; Jeanne M Pimenta; Jennifer S Smith
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

7.  Next generation sequencing for human papillomavirus genotyping.

Authors:  L Sara Arroyo; Vitaly Smelov; Davit Bzhalava; Carina Eklund; Emilie Hultin; Joakim Dillner
Journal:  J Clin Virol       Date:  2013-08-08       Impact factor: 3.168

8.  Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men.

Authors:  Anna R Giuliano; Beibei Lu; Carrie M Nielson; Roberto Flores; Mary R Papenfuss; Ji-Hyun Lee; Martha Abrahamsen; Robin B Harris
Journal:  J Infect Dis       Date:  2008-09-15       Impact factor: 5.226

9.  Oral human papillomavirus (HPV) infection in men who have sex with men: prevalence and lack of anogenital concordance.

Authors:  Eleanor M King; Richard Gilson; Simon Beddows; Kate Soldan; Kavita Panwar; Carmel Young; Mark Jit; W John Edmunds; Pam Sonnenberg
Journal:  Sex Transm Infect       Date:  2015-04-17       Impact factor: 3.519

Review 10.  Association of genital human papillomavirus infection with HIV acquisition: a systematic review and meta-analysis.

Authors:  Pascale Lissouba; Philippe Van de Perre; Bertran Auvert
Journal:  Sex Transm Infect       Date:  2013-08       Impact factor: 3.519

View more
  2 in total

1.  Concordance of Beta-papillomavirus across anogenital and oral anatomic sites of men: The HIM Study.

Authors:  Emily M Nunes; Rossana V M López; Staci L Sudenga; Tarik Gheit; Massimo Tommasino; Maria L Baggio; Silvaneide Ferreira; Lenice Galan; Roberto C Silva; Eduardo Lazcano-Ponce; Anna R Giuliano; Luisa L Villa; Laura Sichero
Journal:  Virology       Date:  2017-07-11       Impact factor: 3.616

2.  Awareness and Knowledge Levels of 18-Year-Old and Older Individuals Regarding Human Papillomavirus (HPV) and HPV Vaccine in Hatay, Turkey.

Authors:  Ebru Turhan; Sirin Cetin; Meryem Cetin; Fatma Abacigil
Journal:  J Cancer Educ       Date:  2019-04       Impact factor: 2.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.